BlackRock’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.1M | Sell |
4,379,023
-331,674
| -7% | -$2.28M | ﹤0.01% | 2746 |
|
|
2025
Q1 | $13.6M | Sell |
4,710,697
-458,732
| -9% | -$1.32M | ﹤0.01% | 3119 |
|
|
2024
Q4 | $24.3M | Sell |
5,169,429
-537,098
| -9% | -$2.52M | ﹤0.01% | 2881 |
|
|
2024
Q3 | $20.4M | Buy |
5,706,527
+908,005
| +19% | +$3.24M | ﹤0.01% | 2990 |
|
|
2024
Q2 | $29.8M | Buy |
4,798,522
+3,257,313
| +211% | +$20.2M | ﹤0.01% | 2700 |
|
|
2024
Q1 | $14.5M | Sell |
1,541,209
-20,657
| -1% | -$195K | ﹤0.01% | 3107 |
|
|
2023
Q4 | $10.5M | Buy |
1,561,866
+115,928
| +8% | +$783K | ﹤0.01% | 3302 |
|
|
2023
Q3 | $6.42M | Sell |
1,445,938
-68,487
| -5% | -$304K | ﹤0.01% | 3505 |
|
|
2023
Q2 | $5M | Sell |
1,514,425
-2,669,313
| -64% | -$8.81M | ﹤0.01% | 3654 |
|
|
2023
Q1 | $11.9M | Buy |
4,183,738
+914,747
| +28% | +$2.61M | ﹤0.01% | 3157 |
|
|
2022
Q4 | $23.8M | Buy |
3,268,991
+496,647
| +18% | +$3.62M | ﹤0.01% | 2879 |
|
|
2022
Q3 | $22.4M | Buy |
2,772,344
+117,966
| +4% | +$954K | ﹤0.01% | 2927 |
|
|
2022
Q2 | $13M | Buy |
2,654,378
+425,768
| +19% | +$2.09M | ﹤0.01% | 3287 |
|
|
2022
Q1 | $52.7M | Buy |
2,228,610
+20,532
| +0.9% | +$486K | ﹤0.01% | 2513 |
|
|
2021
Q4 | $39.1M | Buy |
2,208,078
+177,205
| +9% | +$3.13M | ﹤0.01% | 2783 |
|
|
2021
Q3 | $57.3M | Buy |
2,030,873
+733,428
| +57% | +$20.7M | ﹤0.01% | 2545 |
|
|
2021
Q2 | $13.6M | Buy |
1,297,445
+168,866
| +15% | +$1.77M | ﹤0.01% | 3467 |
|
|
2021
Q1 | $13.3M | Buy |
1,128,579
+85,295
| +8% | +$1M | ﹤0.01% | 3363 |
|
|
2020
Q4 | $12.2M | Buy |
1,043,284
+384,087
| +58% | +$4.5M | ﹤0.01% | 3202 |
|
|
2020
Q3 | $5.23M | Sell |
659,197
-11,155
| -2% | -$88.5K | ﹤0.01% | 3468 |
|
|
2020
Q2 | $12.3M | Buy |
670,352
+49,287
| +8% | +$901K | ﹤0.01% | 3012 |
|
|
2020
Q1 | $7.42M | Buy |
621,065
+410,689
| +195% | +$4.9M | ﹤0.01% | 3101 |
|
|
2019
Q4 | $3.5M | Buy |
210,376
+115,776
| +122% | +$1.93M | ﹤0.01% | 3553 |
|
|
2019
Q3 | $628K | Buy |
+94,600
| New | +$628K | ﹤0.01% | 4060 |
|